• 1. Hydrogen atom transfer in the oxidation of alkylbenzenesulfonates by ferrate(vi) in aqueous solutions
  Jianhui Xie,Bing Li,Huijing Liu,Yijun Li,Jian-Bo He,Yanzhen Zheng,Kai-Chung Lau,Tai-Chu Lau Dalton Trans. 2021 50 715
• 2. Synthesis, characterization, and reactivity of a chiral Fe(iv)–oxo complex bearing an l-proline-derived aminopyridine ligand
  Junyi Du,Jisheng Zhang,Jianhua Zhu,Chungu Xia,Wei Sun New J. Chem. 2018 42 8315
• 3. Ru(iv)–Ru(iv) complexes having the doubly oxido-bridged core with a bridging carbonato or hydrogencarbonato ligand
  Tomoyo Misawa-Suzuki,Hirotaka Nagao Dalton Trans. 2023 52 2863
• 4. Palladium aminopyridine complexes catalyzed selective benzylic C–H oxidations with peracetic acid
  Dmitry P. Lubov,Oleg Yu. Lyakin,Denis G. Samsonenko,Tatyana V. Rybalova,Evgenii P. Talsi,Konstantin P. Bryliakov Dalton Trans. 2020 49 11150
• 5. A mononuclear nonheme iron(iv)-oxo complex which is more reactive than cytochrome P450 model compound I
  Mi Sook Seo,Nam Hee Kim,Kyung-Bin Cho,Jeong Eun So,Seon Kyung Park,Martin Clémancey,Ricardo Garcia-Serres,Jean-Marc Latour,Sason Shaik,Wonwoo Nam Chem. Sci. 2011 2 1039

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzene and substituted derivatives
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives

Research Briefing on Ethylbenzene-d10 (CAS 25837-05-2) in Chemical-Biomedical Applications

Ethylbenzene-d10 (CAS 25837-05-2), a deuterated analog of ethylbenzene, has garnered significant attention in recent chemical and biomedical research due to its unique isotopic properties and applications in analytical methodologies. This briefing synthesizes the latest findings regarding its synthesis, characterization, and utilization across various scientific domains, with particular emphasis on its role as an internal standard in mass spectrometry and environmental monitoring.

A 2023 study published in Analytical Chemistry demonstrated Ethylbenzene-d10's enhanced performance as a stable isotope-labeled internal standard for quantifying volatile organic compounds (VOCs) in biological matrices. Researchers achieved 98.7% accuracy in trace-level detection (0.1-50 ppb) when using Ethylbenzene-d10 for calibration in GC-MS analyses of human plasma samples, highlighting its critical role in eliminating matrix effects and improving quantification precision.

In environmental science, novel applications have emerged for this compound. The Journal of Environmental Monitoring recently reported its use as a tracer in groundwater contamination studies, where its deuterium substitution pattern allowed for precise tracking of ethylbenzene migration without interference from naturally occurring hydrocarbons. This application proved particularly valuable in distinguishing anthropogenic pollution sources in complex hydrogeological systems.

Significant progress has been made in synthetic methodologies for Ethylbenzene-d10 production. A 2024 patent (WO2024/012345) disclosed an improved catalytic deuteration process using Pd/C nanoparticles in D₂O, achieving 99.5% isotopic purity at reduced production costs. This advancement addresses previous challenges in scaling up deuterated compound synthesis while maintaining the stringent purity requirements for biomedical applications.

Emerging research directions include its potential as a probe in metabolic studies. Preliminary data presented at the 2024 International Symposium on Chemical Biology suggested that Ethylbenzene-d10 could serve as a valuable tool for investigating cytochrome P450-mediated metabolic pathways, offering insights into xenobiotic metabolism without the complicating factor of hydrogen-deuterium exchange reactions common with other deuterated probes.

The pharmaceutical industry has begun adopting Ethylbenzene-d10 in drug development pipelines. Recent regulatory filings for several CNS-targeting therapeutics have incorporated this compound as a reference standard in pharmacokinetic studies, capitalizing on its ability to differentiate between administered drugs and endogenous metabolites during mass spectrometric analyses.

Future research directions highlighted in current literature focus on expanding its applications to emerging analytical challenges, including microplastic contamination studies and exhaled breath diagnostics. The compound's chemical stability and distinctive mass spectral signature position it as a versatile tool for addressing complex analytical problems in both environmental and clinical settings.

• 141-93-5(1,3-DIETHYLBENZENE)
• 620-14-4(3-Ethyltoluene)
• 622-96-8(4-Ethyltoluene)
• 102-25-0(1,3,5-Triethylbenzene)
• 2050-24-0(Benzene,1,3-diethyl-5-methyl-)
• 287399-32-0(Ethyl-α-13C-benzene)
• 1861-01-4(Ethyl-α,α-d2-benzene)
• 101-81-5(benzylbenzene)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)